Cargando…
It is unprecedented: trial management during the COVID-19 pandemic and beyond
The COVID-19 pandemic has presented unique challenges for the clinical trial community, both in the rapid establishment of COVID-19 clinical trials and many existing non-COVID-19 studies either being temporarily paused (whether that is a complete pause or pause in some activities) and/or adapting th...
Autores principales: | Mitchell, Eleanor J., Ahmed, Khaled, Breeman, Suzanne, Cotton, Seonaidh, Constable, Lynda, Ferry, Gillian, Goodman, Kirsteen, Hickey, Helen, Meakin, Garry, Mironov, Katy, Quann, Niamh, Wakefield, Natalie, McDonald, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484918/ https://www.ncbi.nlm.nih.gov/pubmed/32917258 http://dx.doi.org/10.1186/s13063-020-04711-6 |
Ejemplares similares
-
How to deal with a temporary suspension and restarting your trial: our experiences and lessons learnt
por: Constable, Lynda, et al.
Publicado: (2020) -
Verifying participant-reported clinical outcomes: challenges and implications
por: Breeman, Suzanne, et al.
Publicado: (2020) -
Using systematic data categorisation to quantify the types of data collected in clinical trials: the DataCat project
por: Crowley, Evelyn, et al.
Publicado: (2020) -
Telephone calls to boost response rates in the collection of outcome data
por: Breeman, Suzanne, et al.
Publicado: (2013) -
Patient reported clinical outcomes: the challenges and implications for randomised controlled trials
por: Breeman, Suzanne, et al.
Publicado: (2011)